Tissue binding study of experimental radioactive markers
This study uses leftover tissue from surgeries to test how experimental radioactive markers bind to human tissue. It helps researchers understand how these markers might work for future imaging or treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery at Nancy University Hospital after 2019.
- Frozen tissue samples from your surgery or biopsy are available for research.
- You have not objected to your tissue being used for research.
- The tissue sample is in good condition (not degraded, contaminated, or insufficient).
- The tissue sample is fully anonymized (no identifying information).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects health and lab information from adults treated with metabolic radiotherapy in the nuclear medicine department. It may help doctors better understand how these treatments work for thyroid cancer, neuroendocrine tumors, or prostate cancer.
This trial studies whether analyzing leftover tissue from cancer surgery can help researchers learn more about tumors. It may help improve future diagnosis or treatment by making use of tissue that would otherwise be discarded.
This study uses tumor tissue from real patients to create lab models that can help researchers test treatments. You might be able to join if you need a biopsy or surgery for care and it’s safe to collect a small amount of tissue for research.
This study looks at proteins and imaging patterns (from tissue, fluid near the tumor, and blood) to better understand breast cancer markers. It may help researchers find clues that doctors can use to evaluate breast nodules and newly diagnosed invasive breast cancer.
This study looks at breast cancer samples taken by biopsy to see how tissue “molecular markers” relate to how you respond to therapy and how the cancer behaves. It may help researchers better match future treatments to the biology of your tumor.
This study looks at tumor tissue and/or blood “biomarkers” to help predict whether a solid tumor will respond well to radiation therapy. It may help doctors choose more effective treatments in the future, and it may guide your care during radiotherapy if you qualify.
Hear when a new Tissue Model trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.